Literature DB >> 14880760

Normal and abnormal variations and clinical significance of the one-minute and total serum bilirubin determinations.

L ZIEVE, E HILL, M HANSON, A B FALCONE, C J WATSON.   

Abstract

Entities:  

Keywords:  LIVER FUNCTION TESTS

Mesh：

Substances：

Year:  1951        PMID： 14880760

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN： 0022-2143


× No keyword cloud information.
  8 in total

1.  Studies of the dipyrrylmethene ("fuscin") pigments. III. The variable fate of bilirubin depending upon conjugation and other factors.

Authors:  A S GILBERTSEN; C J WATSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  The preparation of crystalline bilirubin-C14.

Authors:  J D OSTROW; L HAMMAKER; R SCHMID
Journal:  J Clin Invest       Date:  1961-08       Impact factor: 14.808

3.  Effects of sulfhydryl inhibition on red blood cells. II. Studies in vivo.

Authors:  H S JACOB; J H JANDL
Journal:  J Clin Invest       Date:  1962-07       Impact factor: 14.808

4.  The treatment of acute infectious hepatitis. Controlled studies of the effects of diet, rest, and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities.

Authors:  T C CHALMERS; R D ECKHARDT; W E REYNOLDS; J G CIGARROA; N DEANE; R W REIFENSTEIN; C W SMITH; C S DAVIDSON
Journal:  J Clin Invest       Date:  1955-07       Impact factor: 14.808

5.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

6.  Evaluation of hepatic dysfunction.

Authors:  H W SMITH; J J NORDLAND
Journal:  Am J Dig Dis       Date:  1957-10

7.  The destruction of red cells by antibodies in man. II. Pyrogenic, leukocytic and dermal responses to immune hemolysis.

Authors:  J H JANDL; A S TOMLINSON
Journal:  J Clin Invest       Date:  1958-08       Impact factor: 14.808

8.  Indirect hyperbilirubinemia in HBV carriers.

Authors:  K Miura; S Suzuki; S Tanaka; R Kinoshita; H Uchino; S Hirose; T Nakagawa; Y Imai
Journal:  Gastroenterol Jpn       Date:  1980
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.